CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CELG-RI

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jul '27
CELG-RIPhase 2

Relatlimab Phase 2 Est. Readout

Relatlimab
Jul 2027~
CT.gov
00%
Dec '26
CELG-RIPhase 2

Relatlimab Phase 2 Est. Readout

Relatlimab
Dec 2026~
CT.gov
00%
Oct '26
CELG-RIPhase 2

Relatlimab Phase 2 Est. Readout

Relatlimab
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Advanced Gastric Cancer

View Full Landscape
Drug Information

Target Indication

Advanced Gastric Cancer

Clinical Trial

NCT02935634

Last updated: 2/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.